In particular, SGLT1 overexpression in tumor cells not only increases glucose uptake but also promotes tumor progression via interaction with the ligand-activated EGFR signaling pathway30, suggesting that SGLT1 may have more functions than previously known. The gene discussed is SLC5A1; the disease is neoplasm.